190. J Hematol Oncol. 2018 Apr 18;11(1):56. doi: 10.1186/s13045-018-0599-z.Correction to: miR-182-5p promotes hepatocellular carcinoma progression byrepressing FOXO3a.Cao MQ(1)(2), You AB(3), Zhu XD(1), Zhang W(2), Zhang YY(1), Zhang SZ(1), ZhangKW(4), Cai H(1), Shi WK(1), Li XL(1), Li KS(1), Gao DM(1), Ma DN(5), Ye BG(6),Wang CH(7), Qin CD(8), Sun HC(9), Zhang T(10), Tang ZY(11).Author information: (1)Department of Hepatobiliary Surgery, Liver Cancer Institute and ZhongshanHospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.(2)Department of Hepatobiliary Surgery, Tianjin Medical University CancerInstitute and Hospital, National Clinical Research Center for Cancer, Tianjin'sClinical Research Center for Cancer, Key Laboratory of Cancer Prevention andTherapy, Tianjin, 300060, China.(3)Key laboratory of Carcinogenesis and Translational Research (Ministry ofEducation/Beijing), Division of Etiology, Peking University Cancer Hospital andInstitute, Haidian District, Beijing, 100142, China.(4)Department of General Surgery, Xinhua Hospital, School of Medicine, ShanghaiJiao Tong University, Shanghai, 200092, China.(5)Department of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou,310022, Zhejiang, China.(6)Department of Organ Transplantation, Changhai Hospital, The Second MilitaryMedical University, Shanghai, 200433, China.(7)Department of Liver Surgery, Fudan University Shanghai Cancer Center, CancerHospital, Shanghai, 200032, China.(8)Department of Breast Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou,310022, Zhejiang, China.(9)Department of Hepatobiliary Surgery, Liver Cancer Institute and ZhongshanHospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.sun.huichuan@zs-hospital.sh.cn.(10)Department of Hepatobiliary Surgery, Tianjin Medical University CancerInstitute and Hospital, National Clinical Research Center for Cancer, Tianjin'sClinical Research Center for Cancer, Key Laboratory of Cancer Prevention andTherapy, Tianjin, 300060, China. zhangti@tjmuch.com.(11)Department of Hepatobiliary Surgery, Liver Cancer Institute and ZhongshanHospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.zytang88@163.com.Erratum for    J Hematol Oncol. 2018 Jan 24;11(1):12.The original article [1] contains an error in Fig.Â 5a whereby the Western blotbands representing CyclinD1 have mistakenly been duplicated over the Western blotbands intended to represent SGK.DOI: 10.1186/s13045-018-0599-z PMCID: PMC5907218PMID: 29669588 